DOI:
10.1055/s-00000142
Frauenheilkunde up2date
LinksClose Window
References
Colombo N, Gadducci A, Sehouli J. et al.
LBA30 INOVATYON study: Randomized phase III international study comparing trabectedin/PLD followed by platinum at progression vs. carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6–12 months after last platinum line.
Ann Oncol 2020;
31: S1161
We do not assume any responsibility for the contents of the web pages of other providers.